Related Experiment Video

Updated: Jun 14, 2026

Monitoring of Systemic and Hepatic Hemodynamic Parameters in Mice
16:09

Monitoring of Systemic and Hepatic Hemodynamic Parameters in Mice

Published on: October 4, 2014

C.m.a.R.s.p., C.m.a.I.f. And lancet performance fund quarterly report

B E Freamo

    Canadian Medical Association Journal
    |March 24, 2010
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
    12:22

    A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line

    Published on: December 30, 2012

    Related Experiment Videos

    Last Updated: Jun 14, 2026

    Monitoring of Systemic and Hepatic Hemodynamic Parameters in Mice
    16:09

    Monitoring of Systemic and Hepatic Hemodynamic Parameters in Mice

    Published on: October 4, 2014

    A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
    12:22

    A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line

    Published on: December 30, 2012

    Related Concept Videos

    PI3K/mTOR/AKT Signaling Pathway01:22

    PI3K/mTOR/AKT Signaling Pathway

    The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...

    Articles linked to this work by shared authors, journal, and citation graph.

    Medical Device Industry Payments and Utilization of Corresponding Devices.

    JAMA network open·2026

    Growing fees, modest signals: Evolution of municipal waste charges in Spain (2015-2024).

    Waste management & research : the journal of the International Solid Wastes and Public Cleansing Association, ISWA·2026

    Predictors of Medical Debt Sent to Collections after Radiation Therapy.

    International journal of radiation oncology, biology, physics·2026

    Effect of an out-of-pocket insulin cap in Medicare part D.

    Health affairs scholar·2026

    Changes in Medication Use After Medicare Part D Annual Out-of-Pocket Spending Caps.

    JAMA health forum·2026

    Betting on the Body: Private Equity Portfolio Funding of Medical Malpractice Litigation and the Financialization of Patient Justice.

    Journal of law and health·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us